French biotech armed with Se­ries A looks to build out man­u­fac­tur­ing fa­cil­i­ty for plant-based pro­tein tech

Us­ing plant-based sup­ply to man­u­fac­ture vac­cines and oth­er phar­ma­ceu­ti­cal ma­te­ri­als has be­come more preva­lent in the biotech space, but one French biotech is look­ing to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER